In 2023, Henry O. Gosebruch earned $9.38M in total compensation at Neumora Therapeutics, Inc., including $337.50K salary, $2.52M bonus and $6.52M in stock. Most recently acquired 80,000 shares in Feb 2024. Currently holds stock worth $104.80M. Has donated $17.95M in stock to charitable causes. Led Neumora Therapeutics, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Henry O. Gosebruch, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$9.38M
Salary
$337.50K
Bonus
$2.52M
Other
$6.56K
Salary
$337.50KBoard Justification
The compensation structure is designed to align with individual performance, corporate targets, and long-term business objectives, ensuring competitiveness and retention.
Bonus
$2.52MBoard Justification
The bonus includes a sign-on bonus of $2,500,000 and a discretionary adjustment based on overall corporate performance for 2023.
Other Compensation
$6.56KBoard Justification
Other compensation includes 401(k) matching contributions, electronics allowance, and gifts of consumer goods.
Restricted Stock
Board Justification
The stock award of 382,345 shares was granted upon exercising a stock purchase right, which is subject to a risk of forfeiture until certain conditions are met.
Performance Metrics
The performance metrics for the bonus are based on the achievement of corporate goals.
Henry O. Gosebruch
Ex-CEO of Neumora Therapeutics, Inc.
Education
B.S.E. in Finance from the Wharton School at the University of Pennsylvania
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
June 10, 1973 - 52 years ago
CEO of Neumora Therapeutics, Inc. for
1 year 7 months (Jul 2023 - Feb 2025)
Previous Experience
Executive Vice President and Chief Strategy Officer at AbbVie
Holdings
Track Henry O. Gosebruch's stock holdings and portfolio value over time.
Total Stock Sold
$43.16M
$43.16M
318,770 ABBV shares
What if they kept their stock?
If Henry O. Gosebruch didn't sell their stock, today they would have:
Extra ABBV318,770 shares worth $72.91M.
This is 68.94% and $29.75M more than what they got when they sold the stock.
Charitable Transactions
78,500 shares
ABBV
Recent Charitable Transactions
30,000 shares
ABBV
Sep 7, 2021
Charity
18,500 shares
ABBV
Apr 6, 2020
Charity
30,000 shares
ABBV
Aug 14, 2019
Charity
Insider Trading
Henry O. Gosebruch's recent stock transactions, purchases, and sales filed with the SEC.
80,000 shares
NMRA
Feb 14, 2024
Received
$189.37K
NMRA at $12.62/share
Sep 19, 2023
Purchase
$13.01M
ABBV at $155.00/share
May 16, 2022
Sale
$13.01M
ABBV at $155.00/share
May 16, 2022
Sale
$3.70M
ABBV at $148.12/share
Mar 1, 2022
Sale
$2.23M
ABBV at $148.43/share
Feb 25, 2022
Sale
$3.70M
ABBV at $148.12/share
Mar 1, 2022
Sale
68,068 shares
ABBV
Feb 17, 2022
Received
30,000 shares
ABBV
Sep 7, 2021
Charity
Rivals
Compare Henry O. Gosebruch with competitor CEOs and industry peers.